Efficacy, safety and tolerability of imeglimin in patients with type 2 diabetes mellitus: A meta‐analysis of randomized controlled trials.

Autor: Hagi, Katsuhiko1 (AUTHOR) katsuhiko.hagi@sumitomo-pharma.co.jp, Nitta, Masahiro1 (AUTHOR), Watada, Hirotaka2 (AUTHOR), Kaku, Kohei3 (AUTHOR), Ueki, Kohjiro4 (AUTHOR)
Zdroj: Journal of Diabetes Investigation. Nov2023, Vol. 14 Issue 11, p1246-1261. 16p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje